Search

You searched for "outcomes"

1207 results found

Discussing treatment modalities for bilateral wet AMD

1 December 2014 | | Retina / Uvea / Vitreous
A 65-year-old lady with bilateral wet AMD and vision of 6/24 comes with an internet search about current therapies. How do you explain the various treatment modalities available? There are two NICE approved treatments for wet age-related macular degeneration (AMD)....

Cataract surgery in uveitis patients

1 February 2016 | | Cataract and Refractive
Cataract formation is a common complication of uveitis, causing up to 40% of vision loss in these patients. Cataract results from inflammation +/- corticosteroid therapy and is usually posterior subcapsular, but a small proportion have a rapid increase in nuclear...

Building research capacity through the VISION 2020 LINKS Programme

1 August 2017 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
The aim is to build capacity for research in the region covered by the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA). The project will build research capacity in three ophthalmology training institutions by ‘training the trainers’ and...

The management of retinal vein occlusions: a summary

1 February 2015 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Imaging, Ophthalmology, Retina / Uvea / Vitreous
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...

Joe Scott joins Mainline Instruments as Retinal Product Specialist

5 January 2023 | Recruitment & Personnel
Mainline Instruments welcomes the new appointment of Joe Scott to the Mainline Sales Team as Retinal Product Specialist. We believe that through his experience, Joe has the knowledge and skillset to deliver real value to our customers and staff.

AOP responds to GOC consultation on contact lens care

7 September 2023 | contact lens, AOP, GOC, aftercare
The regulator is reviewing the process for verifying contact lens specifications and the definition of patient aftercare.

Warrington welcomes new ophthalmology hospital

20 December 2023 | CHEC, Pheonix House, community services, ophthalmology, Jose Bailey
CHEC’s new centrally located centre set to reduce NHS waiting times and increase patient choice.

Optometrists and dispensing opticians now eligible for Blue Light Card discount scheme

31 January 2024 | AOP, optometry, optometrist, optical, discounts, rewards, NHS staff
The AOP welcomes the move, which recognises the important healthcare service provided by the optometry profession.

Obituary: a heartfelt goodbye to Roger Pope

3 May 2024 | optician, optometry, obituraries, Roger Pope, obituary
One of the most admired of UK opticians, Roger Pope, holder of two Royal Warrants, has sadly passed away leaving a legacy as the greatest colleague and friend to the optical community.

100 years of insulin

3 October 2022 | | Ophthalmology
*Joint first authors The centenary of the discovery of insulin is a time to celebrate one of the most significant scientific discoveries of the 20th century. Background Before 1923, Type 1 diabetes mellitus [T1DM] resulted in death from severe ketoacidosis...

What's trending Oct/Nov 2021

1 October 2021 | | Ophthalmology, Optometry, Cataract and Refractive, Retina / Uvea / Vitreous, Emergency Ophthalmology
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #cataracts #holography #simulation Cataracts are the major cause of blindness globally and innovating novel management strategies remains as important as ever...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.